Detailed Explanation
Enrollment represents the transition from candidate to participant, the formal point at which an individual who has completed screening, met all eligibility criteria, and provided informed consent becomes an active subject in the clinical trial. This milestone triggers regulatory counting for enrollment targets and initiates the participant's involvement in study procedures. The enrollment process must be executed precisely, with clear documentation demonstrating that all prerequisites were satisfied before enrollment occurred.